Ostatní
Návod 
Qiagen N.V.
QGEN
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
9.4B
Obrat
2B
Zisk
0B
Aktiva
7B
Dluh
2B
ROE
0%
ROA
0%
PE
20
PS
4
Cena 1R
38-52
⌀ Cena
46.00
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
04-02-2026
Poslední dividenda
29-01-2025
Profil
QIAGEN N.V. nabízí řešení pro přehlednost, která přeměňují biologické materiály na molekulární poznatky po celém světě. Společnost zajišťuje primární spotřební materiál pro technologii odběru vzorků, jako jsou sestavy pro stabilizaci a čištění nukleových jader pro primární materiály vzorků, ruční a automatizované zpracování pro genotypizaci, expresi genů a virovou a bakteriální analýzu, jakož i technologie křemičitých membrán a magnetických korálků; spotřební materiál pro sekundární technologii odběru vzorků, včetně sestav a součástí pro čištění nukleových kyselin ze sekundárních materiálů vzorků; a nástroje pro čištění a příslušenství nukleové kyseliny. Poskytuje také test uvolňování interferonu-gama pro testování na TBC a testy pro post-transplantační testování a sledování virové zátěže; testy pro prenatální testování a detekci pohlavně přenosných nemocí a HPV, jakož i testy pro analýzu genomických variant, jako jsou mutace, inzerce, delece a fúze; a testy pro zjištění nástrojů, včetně jednostupňové molekulární analýzy těžko diagnostikovatelných syndromů a integrovaného PCR testu. Kromě toho nabízí PCR spotřební materiál, jako je kvantitativní PCR, reverzní transkripce a kombinační sady pro analýzu genové exprese, genotypizace a nástrojů a technologií pro regulaci genů; spotřební materiál pro stanovení lidské ID a forenzní analýzy, včetně testů STR na lidskou ID a testů na kontaminaci potravin; PCR nástroje se skládají z digitálních PCR řešení; a vyvinuté a konfigurované spotřební materiál OEM. Společnost dále poskytuje předdefinované a zakázkové genové panely NGS, knihovní přípravné sady a komponenty a celou amplifikaci genomu; spotřební materiál a nástroje QIAGEN, jakož i bioinformatická řešení; a zakázkové laboratorní a genomické služby. Slouží k molekulární diagnostice, akademické obci, farmaceutickému a aplikovanému testování. Má dohodu o strategickém spojenectví se společností Sysmex Corporation a OncXerna Therapeutics, stejně jako dohodu s Mirati. Společnost byla založena v roce 1986 a sídlí v nizozemském Venlo.
Sektor
Healthcare
Odvětví
Medical - Diagnostics & Research
Počet zaměstnanců
5700
Založení
1996-06-28
Podobné společnosti
$ 92.19
+ $ 1.41
$ 135.36
+ $ 0.52
$ 40.59
- $ 0.44
$ 52.17
+ $ 0.71
$ 179.21
- $ 0.76
$ 168.50
+ $ 0.45
$ 40.25
- $ 0.56
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 2,090.0 | 2,090.0 | 1,978.2 | 1,965.3 | 2,141.5 | 2,251.7 | 1,870.3 | 1,526.4 | 1,501.8 | 1,417.5 | 1,338.0 | 1,281.0 | 1,344.8 | 1,302.0 | 1,254.5 | 1,169.7 | 1,087.4 | |
| Cost of Revenues | 798.5 | 798.5 | 1,010.9 | 742.4 | 757.0 | 800.8 | 642.5 | 521.2 | 500.9 | 495.0 | 493.3 | 454.6 | 479.8 | 486.5 | 430.4 | 419.9 | 371.9 | |
| Gross Profit | 1,291.5 | 1,291.5 | 967.4 | 1,222.9 | 1,384.6 | 1,450.8 | 1,227.8 | 1,005.3 | 1,001.0 | 922.6 | 844.7 | 826.4 | 864.9 | 815.5 | 824.0 | 749.8 | 715.6 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 540.4 | 532.6 | 533.5 | 483.5 | 521.2 | 501.9 | 496.3 | 458.8 | 509.2 | 475.9 | |
| Cost of Revenues | 223.2 | 201.3 | 199.3 | 174.8 | 187.9 | 193.6 | 461.6 | 167.8 | 164.0 | 177.9 | |
| Gross Profit | 317.3 | 331.3 | 334.3 | 308.7 | 333.3 | 308.3 | 34.8 | 291.0 | 345.1 | 298.0 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 198.5 | 189.9 | 190.0 | 139.1 | 157.4 | 161.9 | 154.1 | 176.1 | 147.2 | 163.6 | 146.1 | 122.5 | 130.6 | 126.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 579.2 | 603.9 | 584.5 | 544.3 | 504.2 | 533.5 | 575.7 | 530.6 | 464.8 | 503.4 | 570.6 | 495.6 | 492.8 | 377.5 | |
| Depreciation & Amortization | 193.7 | 193.7 | 203.3 | 205.3 | 292.7 | 292.9 | 210.0 | 231.5 | 206.4 | 216.4 | 213.1 | 191.5 | 37.1 | 35.5 | 36.1 | 26.7 | 23.5 | |
| Total Operating Expenses | 771.2 | 771.2 | 869.6 | 777.7 | 808.3 | 793.0 | 682.9 | 691.6 | 734.4 | 769.1 | 745.8 | 650.7 | 704.1 | 752.2 | 654.2 | 650.2 | 527.0 | |
| Operating Income | 520.3 | 520.3 | 97.7 | 445.2 | 531.5 | 630.1 | 554.9 | 336.2 | 266.6 | 153.4 | 98.8 | 175.7 | 160.8 | 63.3 | 169.8 | 99.6 | 188.5 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 46.0 | 47.9 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 146.0 | 140.1 | ||
| Depreciation & Amortization | -33.9 | 134.3 | 49.5 | 43.9 | 45.6 | 50.0 | 53.4 | 54.3 | 51.6 | 50.6 | ||
| Total Operating Expenses | 163.4 | 202.1 | 212.4 | 193.3 | 214.2 | 196.2 | 263.2 | 196.0 | 210.7 | 190.8 | ||
| Operating Income | 153.9 | 129.2 | 121.9 | 115.3 | 119.1 | 112.1 | -228.4 | 94.9 | 134.5 | 97.2 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 64.3 | 64.3 | 68.0 | 79.0 | 32.8 | 9.6 | 10.0 | 22.1 | 20.9 | 10.6 | 6.8 | 4.8 | 4.0 | 2.3 | 2.4 | 6.1 | 4.5 | |
| Interest Expense | 33.3 | 33.3 | 43.8 | 53.4 | 58.4 | 54.5 | 73.0 | 74.2 | 67.3 | 49.7 | 39.0 | 37.4 | 39.3 | 30.9 | 23.5 | 25.4 | 27.8 | |
| Other Expense | -30.0 | -30.0 | 23.4 | -15.4 | -18.9 | -4.3 | -400.0 | -414.0 | 5.6 | 0.0 | -9.7 | -10.6 | -6.9 | 2.6 | -3.6 | 15.9 | 7.9 | |
| IBT | 490.3 | 490.3 | 121.1 | 429.8 | 512.6 | 625.8 | 154.9 | -77.8 | 225.7 | 114.4 | 56.9 | 132.5 | 118.5 | 37.3 | 145.2 | 96.2 | 173.1 | |
| Income Tax Expense | 65.4 | 65.4 | 37.6 | 88.5 | 89.4 | 113.2 | 81.3 | -36.3 | 35.4 | 74.0 | -23.4 | 5.6 | 1.3 | -31.8 | 15.6 | 1.3 | 28.8 | |
| Net Income | 424.9 | 424.9 | 83.6 | 341.3 | 423.2 | 512.6 | 73.6 | -41.5 | 190.4 | 40.4 | 80.4 | 127.1 | 116.6 | 69.1 | 129.5 | 96.0 | 144.3 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 20.0 | 15.1 | 13.9 | 15.4 | 15.1 | 18.3 | 16.9 | 17.8 | 19.3 | 20.4 | ||
| Interest Expense | 10.1 | 8.2 | 7.6 | 7.3 | 11.1 | 11.5 | 10.9 | 10.3 | 12.4 | 13.0 | ||
| Other Expense | -44.7 | 5.6 | 4.9 | 4.2 | 6.8 | 4.4 | 5.0 | 7.3 | -15.6 | 2.6 | ||
| IBT | 109.2 | 134.7 | 126.8 | 119.5 | 125.9 | 116.5 | -223.5 | 102.3 | 118.9 | 99.8 | ||
| Income Tax Expense | 1.3 | 4.7 | 30.6 | 28.8 | 37.5 | 18.4 | -40.0 | 21.6 | 21.2 | 22.0 | ||
| Net Income | 107.8 | 130.0 | 96.3 | 90.8 | 88.3 | 98.1 | -183.5 | 80.7 | 97.7 | 77.8 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.39 | $1.54 | $1.92 | $2.32 | $0.33 | $-0.19 | $0.84 | $0.18 | $0.36 | $0.57 | $0.52 | $0.31 | $0.57 | $0.43 | $0.64 | |
| EPS Diluted | $0.00 | $0.00 | $0.38 | $1.57 | $1.90 | $2.28 | $0.32 | $-0.19 | $0.82 | $0.17 | $0.35 | $0.56 | $0.50 | $0.30 | $0.56 | $0.42 | $0.62 | |
| Shares Outstanding | 207.8 | 207.9 | 216.4 | 217.5 | 220.7 | 221.1 | 221.6 | 220.0 | 225.5 | 228.1 | 225.9 | 224.4 | 223.4 | 225.2 | 225.9 | 225.5 | 224.5 | |
| Diluted Shares Outstanding | 207.8 | 207.9 | 218.5 | 217.5 | 223.2 | 225.1 | 227.2 | 220.0 | 233.5 | 233.0 | 230.1 | 228.4 | 232.6 | 233.2 | 231.8 | 230.2 | 231.6 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.41 | $0.44 | $-0.83 | $0.36 | $0.44 | $0.35 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.41 | $0.44 | $-0.83 | $0.36 | $0.44 | $0.35 | ||
| Shares Outstanding | 207.8 | 216.9 | 216.6 | 218.4 | 216.1 | 222.3 | 222.0 | 223.8 | 221.4 | 221.4 | ||
| Diluted Shares Outstanding | 207.8 | 218.5 | 218.2 | 220.2 | 218.0 | 224.0 | 222.0 | 226.6 | 223.8 | 223.7 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 533.6 | 663.6 | 668.1 | 730.7 | 880.5 | 597.0 | 623.6 | 1,159.1 | 657.7 | 439.2 | 290.0 | 392.7 | 330.3 | 394.0 | 221.1 | 828.4 | |
| Short Term Investments | 356.6 | 489.4 | 389.7 | 687.6 | 184.8 | 117.2 | 129.6 | 234.6 | 359.2 | 93.0 | 130.8 | 184.0 | 49.9 | 90.5 | 54.6 | 106.1 | |
| Total Cash & ST Investments | 890.2 | 1,153.0 | 1,057.8 | 1,418.3 | 1,065.3 | 714.3 | 753.2 | 1,393.7 | 1,016.9 | 532.2 | 420.8 | 576.7 | 380.2 | 484.5 | 275.7 | 934.5 | |
| Accounts Receivable | 377.8 | 459.0 | 515.6 | 323.8 | 362.1 | 439.9 | 427.2 | 386.5 | 368.6 | 302.0 | 300.8 | 294.5 | 306.6 | 289.9 | 249.8 | 208.3 | |
| Inventory | 321.8 | 279.3 | 398.4 | 358.0 | 327.5 | 291.2 | 170.7 | 162.9 | 155.9 | 136.6 | 136.6 | 132.3 | 128.1 | 135.3 | 132.2 | 126.6 | |
| Other Current Assets | 240.0 | 68.6 | 175.8 | 294.0 | 354.6 | 182.3 | 105.5 | 109.2 | 106.5 | 66.8 | 70.3 | 113.8 | 66.3 | 55.4 | 90.7 | 95.1 | |
| Total Current Assets | 1,829.8 | 1,959.9 | 2,147.6 | 2,394.0 | 2,109.6 | 1,641.7 | 1,570.2 | 2,155.1 | 1,648.0 | 1,037.6 | 961.6 | 1,148.8 | 920.9 | 994.9 | 748.4 | 1,364.6 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 1,355.6 | 733.8 | 638.8 | 663.6 | 973.0 | 533.6 | 513.7 | 668.1 | 579.9 | 609.5 | |
| Short Term Investments | 334.4 | 220.0 | 324.7 | 489.4 | 507.4 | 356.6 | 379.5 | 389.7 | 435.8 | 722.4 | |
| Total Cash & ST Investments | 1,690.0 | 953.8 | 963.4 | 1,153.0 | 1,480.4 | 890.2 | 893.1 | 1,057.8 | 1,015.8 | 1,331.9 | |
| Accounts Receivable | 375.6 | 385.8 | 340.7 | 459.0 | 345.6 | 355.3 | 343.9 | 515.6 | 342.9 | 327.9 | |
| Inventory | 290.2 | 292.6 | 281.4 | 279.3 | 321.7 | 321.8 | 401.7 | 398.4 | 399.2 | 392.0 | |
| Other Current Assets | 175.2 | 186.9 | 157.4 | 68.6 | 306.4 | 262.5 | 252.0 | 175.8 | 204.5 | 259.6 | |
| Total Current Assets | 2,530.9 | 1,819.0 | 1,742.9 | 1,959.9 | 2,454.1 | 1,829.8 | 1,890.8 | 2,147.6 | 1,962.4 | 2,311.4 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 717.8 | 753.6 | 870.3 | 662.2 | 638.2 | 528.6 | 455.2 | 511.7 | 494.3 | 436.7 | 442.9 | 428.1 | 445.0 | 418.9 | 371.8 | 345.7 | |
| Goodwill | 2,449.4 | 2,425.4 | 2,475.7 | 2,352.6 | 2,350.8 | 2,389.1 | 2,140.5 | 2,108.5 | 2,012.9 | 1,925.5 | 1,875.7 | 1,888.0 | 1,855.7 | 1,759.9 | 1,733.7 | 1,352.3 | |
| Intangible Assets | 345.5 | 303.8 | 526.8 | 544.8 | 627.4 | 883.6 | 632.4 | 475.0 | 499.3 | 557.2 | 636.4 | 726.9 | 790.4 | 853.9 | 819.5 | 753.3 | |
| Long-Term Investments | 38.7 | 0.0 | 29.5 | 23.5 | 190.4 | 15.4 | 192.3 | -9.4 | -4.8 | -23.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | -142.0 | 246.9 | 65.3 | 254.4 | 157.6 | 423.8 | 188.4 | 464.5 | 349.4 | 306.4 | 271.0 | 258.4 | 71.3 | 60.0 | 56.2 | 61.0 | |
| Total Long-Term Assets | 3,754.9 | 3,729.8 | 3,967.6 | 3,893.8 | 4,037.4 | 4,329.5 | 3,665.4 | 3,593.3 | 3,390.5 | 3,270.6 | 3,228.1 | 3,305.6 | 3,167.5 | 3,131.1 | 3,008.0 | 2,549.4 | |
| Total Assets | 5,584.6 | 5,689.6 | 6,115.2 | 6,287.7 | 6,147.0 | 5,971.2 | 5,235.6 | 5,748.3 | 5,038.5 | 4,308.2 | 4,189.7 | 4,454.4 | 4,088.4 | 4,125.9 | 3,756.5 | 3,914.0 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 897.6 | 874.9 | 803.7 | 753.6 | 759.9 | 717.8 | 762.5 | 870.3 | 706.0 | 706.8 | |
| Goodwill | 2,554.5 | 2,552.0 | 2,448.6 | 2,425.4 | 2,486.2 | 2,449.4 | 2,448.9 | 2,475.7 | 2,434.5 | 2,456.5 | |
| Intangible Assets | 297.2 | 314.2 | 290.5 | 303.8 | 330.8 | 345.5 | 502.0 | 526.8 | 542.6 | 570.2 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 19.3 | 0.0 | 0.0 | 29.5 | 85.6 | 126.2 | |
| Other Long-Term Assets | 273.3 | 263.6 | 259.7 | 246.9 | 219.8 | 242.2 | 201.7 | 26.7 | 261.2 | 302.3 | |
| Total Long-Term Assets | 4,022.6 | 4,004.8 | 3,802.5 | 3,729.8 | 3,816.1 | 3,754.9 | 3,915.2 | 3,967.6 | 3,944.3 | 4,035.8 | |
| Total Assets | 6,553.5 | 5,823.8 | 5,545.4 | 5,689.6 | 6,270.2 | 5,584.6 | 5,805.9 | 6,115.2 | 5,906.7 | 6,347.3 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 76.1 | 83.3 | 84.2 | 98.7 | 101.2 | 118.2 | 84.8 | 69.4 | 59.2 | 51.2 | 52.3 | 46.1 | 50.9 | 51.3 | 59.8 | 47.8 | |
| Short-Term Debt | 492.7 | 77.8 | 610.2 | 389.6 | 847.6 | 66.0 | 285.2 | 503.1 | 1.4 | 1.0 | 0.9 | 131.1 | 0.2 | 0.9 | 143.9 | 75.8 | |
| Other Current Liabilities | 396.1 | 286.8 | 306.0 | 417.2 | 505.3 | 372.6 | 532.8 | 354.3 | 214.9 | 211.6 | 165.3 | 205.2 | 235.3 | 220.8 | 245.0 | 234.3 | |
| Current Liabilities | 1,034.9 | 543.6 | 1,079.3 | 974.5 | 1,517.5 | 613.8 | 951.3 | 972.2 | 324.8 | 308.4 | 268.4 | 431.6 | 337.0 | 300.4 | 481.7 | 388.4 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 74.8 | 82.3 | 69.7 | 83.3 | 79.0 | 76.1 | 75.3 | 84.2 | 76.9 | 83.9 | |
| Short-Term Debt | 499.6 | 559.2 | 55.7 | 77.8 | 555.3 | 492.7 | 590.5 | 610.2 | 100.6 | 500.1 | |
| Other Current Liabilities | 399.0 | 486.8 | 391.6 | 286.8 | 494.3 | 466.2 | 359.3 | 306.0 | 346.9 | 394.4 | |
| Current Liabilities | 973.4 | 1,128.3 | 516.9 | 543.6 | 1,128.6 | 1,034.9 | 1,025.2 | 1,079.3 | 524.4 | 978.5 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 908.9 | 1,338.1 | 1,000.9 | 1,471.9 | 1,094.1 | 1,960.8 | 1,421.1 | 1,671.1 | 1,758.3 | 1,067.1 | 1,059.6 | 1,041.0 | 845.3 | 846.0 | 446.0 | 797.2 | |
| Capital Leases | 0.0 | 24.3 | 79.1 | 22.2 | 22.0 | 109.0 | 18.7 | 0.1 | 1.4 | 1.0 | 0.9 | 1.1 | 4.7 | 4.2 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 17.5 | 37.6 | 46.0 | 23.4 | 63.4 | 76.7 | 40.6 | 75.7 | 117.3 | 143.8 | 196.4 | 207.1 | 200.7 | |
| Total Liabilities | 2,179.4 | 2,122.3 | 2,307.4 | 2,821.1 | 3,050.4 | 3,488.1 | 2,699.0 | 3,113.4 | 2,497.5 | 1,701.1 | 1,627.7 | 1,796.4 | 1,364.5 | 1,401.6 | 1,198.7 | 1,437.6 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 1,627.6 | 884.8 | 1,352.6 | 1,338.1 | 1,364.6 | 908.9 | 912.8 | 1,000.9 | 1,382.4 | 1,387.9 | |
| Capital Leases | 0.0 | 0.0 | 0.0 | 24.3 | 0.0 | 0.0 | 0.0 | 79.1 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 12.8 | -13.3 | -14.1 | |
| Total Liabilities | 2,904.1 | 2,318.3 | 2,137.5 | 2,122.3 | 2,740.2 | 2,179.4 | 2,206.3 | 2,307.4 | 2,213.0 | 2,723.7 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 2.6 | 2.6 | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.7 | 2.7 | |
| Retained Earnings | 2,265.5 | 2,448.1 | 2,456.8 | 2,160.2 | 1,465.1 | 758.5 | 868.8 | 1,069.0 | 1,027.2 | 929.6 | 968.4 | 991.0 | 1,050.2 | 1,029.4 | 855.9 | 759.9 | |
| Comprehensive Income | -431.5 | -474.5 | -433.8 | -404.1 | -326.7 | -239.6 | -309.6 | -310.6 | -220.8 | -333.8 | -259.2 | -134.7 | -4.2 | 44.0 | 15.9 | 64.8 | |
| Total Common Equity | 3,405.3 | 3,567.3 | 3,807.8 | 3,466.6 | 3,096.6 | 2,483.0 | 2,536.6 | 2,635.0 | 2,541.0 | 2,607.1 | 2,559.9 | 2,649.7 | 2,714.3 | 2,714.7 | 2,548.3 | 2,476.4 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 2.5 | 2.5 | 2.5 | 2.6 | 2.6 | 2.6 | 2.6 | 2.7 | 2.7 | 2.7 | |
| Retained Earnings | 2,647.6 | 2,518.0 | 2,499.0 | 2,448.1 | 2,362.5 | 2,265.5 | 2,486.1 | 2,456.8 | 1,922.2 | 1,865.2 | |
| Comprehensive Income | -384.3 | -387.7 | -441.6 | -474.5 | -413.5 | -431.5 | -424.2 | -433.8 | -438.7 | -417.9 | |
| Total Common Equity | 3,649.4 | 3,505.5 | 3,407.9 | 3,567.3 | 3,530.0 | 3,405.3 | 3,599.6 | 3,807.8 | 3,693.7 | 3,623.6 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 1,401.6 | 1,415.9 | 1,611.1 | 1,861.5 | 1,941.8 | 2,026.7 | 1,706.4 | 2,174.2 | 1,758.3 | 1,067.1 | 1,059.6 | 1,172.1 | 845.5 | 847.0 | 590.0 | 873.0 | |
| Book Value | 3,405.3 | 3,567.3 | 3,807.8 | 3,466.6 | 3,096.6 | 2,483.0 | 2,536.6 | 2,635.0 | 2,541.0 | 2,607.1 | 2,562.0 | 2,658.0 | 2,723.9 | 2,724.4 | 2,557.8 | 2,476.4 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 3,649.4 | 3,505.5 | 3,407.9 | 3,567.3 | 3,530.0 | 3,405.3 | 3,599.6 | 3,807.8 | 3,693.7 | 3,623.6 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 72.7 | 424.9 | 83.6 | 341.3 | 423.2 | 512.6 | 73.6 | -41.5 | 190.4 | 40.4 | 80.3 | 126.9 | 117.2 | 69.1 | 129.5 | 94.9 | 144.3 | |
| Depreciation & Amortization | 209.9 | 197.1 | 203.3 | 205.3 | 208.4 | 214.9 | 210.0 | 231.5 | 206.4 | 216.4 | 213.1 | 191.5 | 200.8 | 199.4 | 197.9 | 167.4 | 142.8 | |
| Stock-Based Compensation | 49.0 | 50.4 | 43.6 | 47.1 | 49.5 | 38.4 | 40.9 | 65.9 | 40.1 | 34.4 | 28.3 | 27.6 | 42.2 | 37.9 | 25.4 | 19.5 | 13.6 | |
| Change Working Capital | 18.0 | -34.5 | 135.5 | -187.0 | -31.9 | -130.0 | 16.8 | -44.3 | -95.2 | -67.2 | 10.3 | -81.1 | -78.8 | 5.7 | -83.9 | -42.9 | -15.9 | |
| Change In Accounts Receivable | -50.2 | 0.0 | 12.2 | -55.1 | 15.5 | -7.4 | -14.7 | -39.6 | -41.8 | -34.2 | -12.2 | -24.8 | -16.6 | -14.9 | -14.3 | -28.2 | -6.9 | |
| Change In Accounts Payable | -3.2 | 0.0 | 1.4 | -22.4 | -1.8 | -6.0 | 8.4 | 9.3 | 7.0 | 4.3 | -1.5 | 7.7 | -5.5 | -6.8 | -9.9 | 7.3 | 3.5 | |
| Change In Inventories | 51.2 | 0.0 | 87.8 | -44.8 | -62.0 | -81.8 | -107.6 | -30.0 | -36.9 | -21.6 | -20.3 | -33.2 | -41.8 | -17.5 | -20.4 | -15.9 | 2.3 | |
| Other Non-cash Items | 296.7 | 36.5 | 230.7 | 41.9 | 75.6 | 8.4 | 165.2 | 174.6 | 41.0 | 23.2 | 75.6 | 89.9 | 47.9 | 15.0 | -1.3 | 37.7 | -14.1 | |
| Cash from Operations | 575.7 | 0.0 | 0.0 | 459.5 | 715.3 | 639.0 | 492.3 | 330.8 | 359.5 | 286.8 | 341.6 | 317.5 | 288.0 | 259.0 | 244.9 | 244.8 | 250.8 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 107.8 | 130.0 | 96.3 | 90.8 | 88.3 | 98.1 | -183.5 | 80.7 | 97.7 | 77.8 | |
| Depreciation & Amortization | 50.4 | 52.2 | 49.5 | 43.9 | 45.6 | 50.0 | 53.4 | 54.3 | 51.6 | 50.6 | |
| Stock-Based Compensation | 16.6 | 10.7 | 10.8 | 12.3 | 10.8 | 8.9 | 10.1 | 13.8 | 12.0 | 13.1 | |
| Change Working Capital | 48.6 | -26.4 | -4.1 | -14.6 | 31.3 | 16.8 | 105.7 | -18.3 | -40.5 | -28.8 | |
| Change In Accounts Receivable | 13.8 | 8.6 | -35.3 | 12.9 | -19.7 | 19.4 | -18.9 | 31.5 | -46.1 | -16.7 | |
| Change In Accounts Payable | 0.0 | -12.7 | 12.4 | -6.0 | 2.6 | -3.8 | 1.6 | 1.2 | -5.0 | -1.0 | |
| Change In Inventories | -4.6 | -0.9 | 3.3 | 2.2 | 20.1 | 12.7 | 70.5 | -15.5 | 14.0 | -17.8 | |
| Other Non-cash Items | -15.5 | 2.0 | 5.4 | 7.9 | 6.2 | 16.3 | 205.2 | 3.0 | 5.5 | 19.3 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 151.4 | 124.7 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -170.5 | -207.1 | -167.2 | -162.8 | -149.3 | -206.5 | -304.2 | -274.9 | -150.8 | -124.4 | -93.9 | -117.5 | -97.0 | -118.7 | -128.1 | -121.4 | -123.9 | |
| Acquisitions | -5.1 | -291.2 | 0.0 | -149.5 | -63.7 | -16.6 | -239.6 | -67.1 | -172.8 | -50.5 | -90.5 | -66.9 | -160.4 | -170.5 | -132.0 | -457.5 | -37.0 | |
| Investments | -512.5 | -371.8 | -688.4 | -979.3 | -1,387.1 | -400.3 | -50.2 | -299.1 | -577.4 | -455.3 | -519.8 | -323.6 | -429.6 | -24.7 | -48.1 | -206.1 | -110.1 | |
| Sales of Investment | 916.1 | 597.1 | 585.0 | 1,270.6 | 883.1 | 359.6 | 207.3 | 396.1 | 691.8 | 189.0 | 533.8 | 367.7 | 275.8 | 63.1 | 6.0 | 242.6 | 52.0 | |
| Other Investing Activities | -49.5 | 0.0 | 0.0 | -66.6 | -9.8 | 61.5 | -66.6 | 22.7 | -2.1 | -23.0 | -8.7 | -5.9 | 3.6 | -1.0 | 1.3 | 2.0 | 3.5 | |
| Cash from Investing | 178.5 | 0.0 | 0.0 | -87.7 | -726.8 | -202.4 | -453.3 | -222.3 | -211.4 | -464.3 | -179.1 | -146.2 | -407.6 | -251.7 | -300.9 | -540.3 | -215.5 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -71.6 | -50.4 | -40.2 | -44.3 | -48.7 | -43.7 | -38.2 | -38.4 | -52.2 | -41.0 | |
| Acquisitions | -224.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -5.1 | |
| Investments | -1.1 | -198.4 | -110.0 | -26.3 | -125.3 | -304.4 | -73.1 | -185.5 | -61.1 | -192.7 | |
| Sales of Investment | 75.0 | 120.0 | 212.4 | 189.7 | 141.8 | 155.3 | 95.2 | 192.6 | 118.8 | 472.8 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -63.9 | 14.4 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -58.5 | 248.4 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -538.3 | 0.0 | 0.0 | -436.8 | -480.0 | -41.3 | -616.7 | -506.4 | -1.3 | -1.4 | -8.1 | -253.0 | -391.6 | -8.0 | -150.8 | -473.6 | -53.3 | |
| Debt Issued | 51.8 | 1,415.9 | -195.2 | 186.4 | 399.7 | -43.6 | 937.1 | 38.5 | 417.3 | 692.6 | 15.6 | 140.5 | 718.2 | 6.4 | 407.8 | 190.5 | 926.3 | |
| Issuance of Common Stock | 36.8 | 0.0 | 0.0 | 0.2 | 0.1 | 7.9 | 7.7 | 2.1 | 4.4 | 6.1 | 6.3 | 10.3 | 12.1 | 25.3 | 16.6 | 8.8 | 11.2 | |
| Repurchase of Common Stock | -324.3 | -307.4 | -292.1 | 0.0 | 0.0 | -100.0 | -64.0 | -74.5 | -104.7 | -61.0 | 0.0 | -20.8 | -126.9 | -86.0 | -35.7 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -622.2 | 0.0 | -567.3 | -769.7 | 0.0 | 0.0 | -785.9 | 0.0 | -400.0 | 0.0 | 0.0 | |
| Other Financing Activities | -358.6 | 0.0 | 0.0 | 2.8 | 354.1 | -17.0 | 1,220.9 | -60.3 | 1,029.3 | 1,213.1 | -8.8 | 4.9 | 1,485.1 | -0.1 | 796.5 | 154.2 | 6.8 | |
| Cash from Financing | -828.0 | 0.0 | 0.0 | -433.8 | -125.8 | -150.4 | -74.3 | -639.1 | 360.4 | 387.2 | -10.6 | -258.6 | 192.8 | -68.8 | 226.6 | -310.6 | -35.2 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 2,127.2 | 683.2 | 35.7 | -7.5 | -504.0 | 518.2 | -101.7 | -107.8 | 128.2 | -405.1 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 36.8 | 0.0 | |
| Repurchase of Common Stock | -2.7 | -9.3 | -10.3 | -280.1 | -0.9 | 0.0 | -27.0 | -292.1 | -0.5 | -4.7 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -44.2 | -401.1 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.4 | -401.1 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -75.9 | 175.5 | -4.5 | -62.6 | -149.8 | 282.5 | -31.2 | -529.7 | 501.4 | 218.5 | 149.2 | -102.7 | 62.4 | -63.7 | 172.9 | -607.3 | 2.9 | |
| Closing Cash Balance | 533.6 | 839.0 | 663.6 | 668.1 | 730.7 | 880.5 | 597.0 | 629.4 | 1,159.1 | 657.7 | 439.2 | 290.0 | 392.7 | 330.3 | 394.0 | 221.1 | 828.4 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -516.6 | 621.8 | 95.1 | -24.8 | -309.4 | 439.3 | 20.0 | -154.4 | 88.1 | -29.6 | |
| Closing Cash Balance | 839.0 | 1,355.6 | 733.8 | 638.8 | 663.6 | 973.0 | 533.6 | 513.7 | 668.1 | 579.9 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 405.2 | 453.3 | 506.4 | 296.7 | 565.9 | 432.5 | 188.0 | 56.0 | 208.7 | 162.4 | 247.7 | 200.0 | 191.0 | 140.3 | 116.8 | 123.4 | 126.8 | |
| Real Free Cash Flow | 356.2 | 402.9 | 462.8 | 249.6 | 516.4 | 394.1 | 147.1 | -9.9 | 168.6 | 127.9 | 219.4 | 172.5 | 148.8 | 102.3 | 91.4 | 103.9 | 113.3 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 117.2 | 119.0 | 120.6 | 95.8 | 141.9 | 138.0 | 127.7 | 94.7 | 99.1 | 83.6 | |
| Real Free Cash Flow | 100.6 | 108.3 | 109.8 | 83.5 | 131.0 | 129.2 | 117.6 | 80.9 | 87.1 | 70.6 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 19.5 | 53.2 | 63 |
| P/S | 4 | 5.3 | 57.8 |
| P/B | 2.3 | 2.9 | 29.8 |
| P/FCF | 20.6 | 77 | 549.4 |
| Market cap | $9.4 | $9.0 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 27 % | 0 % |
| Debt to Income | 500.7 % | 916.1 % | 0 % |
| Debt to Free cash flow | 528.8 % | 13.6 % | 0 % |
| Interest expense percentage | 6.4 % | 4451.8 % | 2.9 % |
| Current ratio | 2.6 | 2.7 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 11.6 % | 6 % | 0 % |
| ROA | 6.5 % | 3.3 % | 0 % |
| CapEx to Revenue | 9.9 % | 10 % | 0 % |
| RaD to Revenue | 0 % | 9.7 % | 0 % |
| ROEM | 366,666.5 | 283846.1 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 61.8 % | 64 % | 47.8 % |
| Operating margin | 24.9 % | 13.6 % | 28 % |
| Net margin | 20.3 % | 11 % | 19.8 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 2.5 % | 0 % |
| Dividend payout percentage | 0 % | 152.1 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 207.8 mil | 229.9 mil |
| Employee count | 5.7 tis | 3.8 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
